Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the membership group’s members; the membership group itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodCalifornia Life Sciences reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 2 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Budget/Appropriations8/8
- Copyright/Patent/Trademark8/8
- Health Issues8/8
- Labor Issues/Antitrust/Workplace8/8
- Manufacturing8/8
Medical/Disease Research/Clinical Labs 8 of 8 · Medicare/Medicaid 8 of 8 · 5 more · Show all 12
- Medical/Disease Research/Clinical Labs8/8
- Medicare/Medicaid8/8
- Taxation/Internal Revenue Code8/8
- Science/Technology7/8
- Small Business7/8
- Tariff (miscellaneous tariff bills)7/8
- Trade (domestic/foreign)6/8
Bills named in the filings 8 bills, this period
- H.R. 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. Broad bill7 filings
- H.R. 946 ORPHAN Cures Act6 filings
- H.R. 1492 To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.2 filings
- H.R. 1990 American Innovation and R&D Competitiveness Act of 20252 filings
- H.R. 1691, 118th Ensuring Patient Access to Critical Breakthrough Products Act of 20241 filing
3 more, 4 named in only one filing · Show all 8
- H.R. 830, 118th HELP Copays Act1 filing
- H.R. 10545, 118th American Relief Act, 2025 Broad bill1 filing
- H.R. 2673, 118th American Innovation and R&D Competitiveness Act of 2023 Broad bill1 filing
From the filings
“H.R. 1, One Big Beautiful Bill Act, issues related to R&D tax credit. Monitor trade and tariff issues related to pharmaceutical tariffs. Health care IP.”
“Support full funding across HHS departments”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- CMS
- HHS
- NIST
- NIH
- USTR
- SBA
- DOC
The House and Senate appear in every quarter; agencies in all 8 quarters.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by California Life Sciences, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 8 sitting members of Congress in 2025–26.
See every candidate and member California Life Sciences gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in